5 Nov 2022 , 04:09 PM
Net profit of Balaxi Pharmaceuticals rose 28.55% to Rs 15.49 crore in the quarter ended September 2022 as against Rs 12.05 crore during the previous quarter ended September 2021. Sales rose 23.00% to Rs 86.38 crore in the quarter ended September 2022 as against Rs 70.23 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 86.38 | 70.23 | 23 |
| OPM % | 17.08 | 19.98 | – |
| PBDT | 18.87 | 14.15 | 33 |
| PBT | 18.68 | 14.03 | 33 |
| NP | 15.49 | 12.05 | 29 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
